The SEC proposal would substantially expand access to registered offerings by opening Form S-3 shelf registration to significantly more ...

Good day, and welcome to the Viking Therapeutics Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] And as a reminder, this conference call is being recorded today, July 29 ...

An index is a measure (often a numerical value) that can be representative of a particular pattern or state of a system. Climatologists monitor several indices, some ocean-based and some atmospheric, ...

Earnings call Viking Therapeutics reported a Q2 2026 net loss of $128.1M ($1.10/share), nearly doubling YoY due to sharply higher R&D and G&A expenses as phase III obesity trials advanced. Management ...